Clinical Trials in Hiroshima, Japan

Delta Trials hosts 1,188 clinical trials conducted in Hiroshima, Japan, making it a notable site of clinical research activity. These trials covering 799 medical conditions and multiple therapeutic areas, reflecting the scope and diversity of clinical research in this location. Since 2020, 90 trials in this location have been stopped, mirroring broader trends in global research activity. The trial counts on this page reflect the most recent data ingested from ClinicalTrials.gov, tracking research history across multiple versions for Hiroshima.